One striking feature of our results was the increased rate of intra-tumoural growth and reduced survival following platinum treatment of tumours with double Trp53;Pten or Trp53;Nf1 mutations compared to those with Trp53 mutations alone. The gene discussed is NF1; the disease is neoplasm.